Congratulations Dr. Zucker!
The 32nd annual Linda Laubenstein award recognizes Dr. Jason Zucker for his leadership in and unwavering commitment to providing clinical education on sexual health, mpox, and HIV prevention. His work has greatly expanded awareness on these topics among New York State care providers.
Dr. Zucker is an Assistant Professor of Medicine in the Division of Infectious Diseases at Columbia University Medical Center and Assistant Medical Director of the New York City STD Prevention Training Center. He is a trained adult and pediatric infectious diseases physician experienced in providing high-quality, status-neutral HIV and sexual health care to patients of all ages in the NewYork-Presbyterian/Columbia Comprehensive Health Program Sexual Health Clinic.
Dr. Zucker serves as a consultant to the Centers for Disease Control and Prevention (CDC) and leads multiple National Institutes of Health (NIH)-funded studies. His crucial research focuses on using data, behavioral, and implementation science to enhance engagement in sexual health care for individuals living with or at risk of sexually transmitted infections (STIs). He coauthored the New York State Department of Health AIDS Institute (NYSDOH AI) clinical guidance Questions, Answers, and Best Practices for Expedited Partner Therapy (EPT), which informs clinicians about existing regulations that allow expedited treatment of sex partners of individuals diagnosed with gonorrhea, chlamydia, or trichomoniasis, and he is a key member in the New York State Congenital Syphilis Elimination Strategic Planning Group.
Since the start of the 2022 mpox outbreak, Dr. Zucker has been actively involved in the mpox response. He again shared his expertise with the NYSDOH AI by coauthoring the clinical practice guideline Prevention and Treatment of Mpox, which provides evidence-based recommendations on primary prevention, diagnostic testing, and supportive care and treatment of mpox. Dr. Zucker serves as co-vice chair of the NIH-funded Tecovirimat for Human Monkeypox Virus (STOMP) study and co-investigator for the CDC-funded Life after Mpox (LAMP) study. He also serves on the CDC Advisory Committee on Immunization Practices for Mpox Working Group and the writing team for the mpox section of the NIH Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV.
For his passion, expertise, and steadfast commitment to serving the people of New York State and beyond, and for his contribution to the advancement of sexual health and well-being, we are delighted to recognize Dr. Zucker with the 2024 Linda Laubenstein award.
|